Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (138)

71

Precision Medicine for

in: Cancers | 2022

von Daniel R. Principe

72

Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer—Where Are We Now?

in: Cancers | 2022

von Arpit Rao | Nagaishwarya Moka | Daniel A. Hamstra | +1

73

Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited

in: Cancers | 2022

von Karin Byskata | Monika Lukoseviciute | Filippo Tuti | +4

74

Epigenetic Insights on PARP-1 Activity in Cancer Therapy

in: Cancers | 2022

von Giulia Pinton | Sara Boumya | Maria Rosa Ciriolo | +1

75

Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints

in: Cancers | 2022

von Ornella Franzese | Grazia Graziani

76

in: Cancers | 2022

von Jorge Canar | Prima Manandhar-Sasaki | Jill Bargonetti

77

Preventing and Overcoming Resistance to PARP Inhibitors : A Focus on the Clinical Landscape

enthalten in: Cancers | 2021

von Prados-Carvajal, R. | Irving, E. | Lukashchuk, N. | +1

78

PARP Inhibitors and Myeloid Neoplasms : A Double-Edged Sword

enthalten in: Cancers | 2021

von Csizmar, C. | Saliba, A. | Swisher, E. | +1

79

Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer : Time for a Paradigm Shift?

enthalten in: Cancers | 2021

von DiSilvestro, P. | Colombo, N. | Harter, P. | +3

80

PARP Inhibitors and Haematological Malignancies-Friend or Foe?

enthalten in: Cancers | 2021

von Skelding, K. | Lincz, L.